# Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection

> **NCT04354610** · NA · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 73 (actual)

## Conditions studied

- COVID 19

## Interventions

- **PROCEDURE:** Biological samples specific to research
- **PROCEDURE:** Clinical examination
- **PROCEDURE:** Telephone follow-up

## Key facts

- **NCT ID:** NCT04354610
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-27
- **Primary completion:** 2020-12-19
- **Final completion:** 2021-03-26
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2021-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04354610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04354610, "Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04354610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*